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Abstract 
S-acylation, the reversible post-translational lipid 
modification of proteins is an important 
mechanism to control the properties and function 
of ion channels and other polytopic 
transmembrane proteins. However, while 
increasing evidence reveals the role of diverse 
acyl protein transferases (zDHHC) in controlling 
ion channel S-acylation the acyl protein 
thioesterases that control ion channel deacylation 
are very poorly defined. Here we show that 
the  a/b-hydrolase domain-containing protein 17a 
(ABHD17a) deacylates the STREX domain of 
large conductance voltage- and calcium- 
activated potassium (BK) channels inhibiting 
channel activity independently of effects on 
channel surface expression. Importantly, 
ABHD17a deacylates BK channels in a site- 
specific manner as it has no effect on the S-
acylated S0-S1 domain conserved in all BK 
channels that controls membrane trafficking and 
is deacylated by the acyl protein thioesterase 
Lypla1.  Thus, distinct S-acylated domains in the 
same polytopic transmembrane protein can be 
regulated by different acyl protein thioesterases 
revealing mechanisms for generating both 
specificity and diversity for these important 
enzymes to control the properties and functions 
of ion channels. 
 
Introduction 
Protein S-acylation, the dynamic and reversible 
postranslational modification of cysteines 
residues through addition of a fatty acid (typically 
the 16-carbon fatty acid palmitate) via a labile 
thioester bond, is an important modulator of the 
lifecycle of many polytopic transmembrane 
proteins including receptors, transporters and ion 
channels (1–4). Indeed, a large repertoire of pore-
forming and accessory ion channel subunits are 
known to be S-acylated controlling diverse 
channel properties and functions from assembly, 
through trafficking to the cell surface, to regulation 
by diverse signalling cascades. S-acylation is 
mediated by a family of transmembrane zinc 
DHHC (Asp-His-His-Cys) acyl transferases 
(zDHHC) (5–7). For many transmembrane 
proteins we are beginning to understand the 
repertoire of zDHHCs that can show some 
selectivity for different ion channels and even S-
acylated domains in the same protein. In contrast, 
there is a dearth of evidence for the acyl protein 
thioesterase enzymes that remove lipids from 
(deacylation) most polytopic transmembrane 
proteins including ion channels. Classically, two 
members of the serine hydrolase superfamily 
(LYPLA1 and LYPLA2) were thought to be the 
major acyl protein thioesterases that mediate 
deacylation of cytosolic cysteine residues in 
proteins even though it was clear many proteins 
were not controlled by these enzymes (8–10). 
Indeed, additional members of the broader serine 
hydrolase family, in particular the  a/b-hydrolase 
domain-containing protein 17 (ABHD17) family, 
have been identified by activity profiling and 
shown to be functional acyl protein thioesterases 
that are targeted to the plasma membrane and 
deacylate a number of peripheral membrane and 
other proteins including Psd-95, N-Ras, Gap-43, 
and Map6 (11–14). However, the regulation of 
polytopic transmembrane proteins, including ion 
channels,  by a/b-hydrolase domain-containing 
protein or other acyl protein thioesterases of the 
serine hydrolase family, and whether they display 
specificity, is essentially unknown. 
We have previously revealed that the trafficking, 
function and regulation of pore forming subunit 
(Kcnma1) of the large conductance calcium- and 
voltage activated potassium (BK) channel is 
controlled by S-acylation of two distinct domains 
(Figure 1A). The intracellular loop between 
transmembrane domains S0 and S1 (S0-S1 loop) 
is S-acylated at a cluster of conserved cysteine 
residues that controls trafficking to the plasma 
membrane and functional assembly with 
regulatory  b1-accessory subunits (15, 16). This 
domain is largely S-acylated by zDHHC23 that 
promotes membrane trafficking of the a-subunit 
alone and is a target for deacylation by Lypla1 
resulting in channel retention in the trans Golgi 
network (15). In contrast, the alternatively spliced 
stress regulated exon (STREX) introduces an 
additional conserved tandem cysteine motif that 
is S-acylated by a number of zDHHCs, including 
zDHHC17, but not zDHHC23 (17–19). S-
acylation of the STREX domain enhances the 
apparent calcium sensitivity of the channel (17–
19) and determines STREX variant channel 
regulation by AGC-family protein kinase 
dependent phosphorylation (17, 20). However, 
acyl protein thioesterases that deacylate the 
STREX domain have not been identified. 
In this manuscript we sought to i) characterise 
acyl protein thioesterases that deacylate the 
STREX domain; ii) to establish whether these 
acyl transferases display specificity between the 
STREX and S0-S1 loop domains and iii) 
determine the functional impact of identified acyl 
protein thioesterases on channel trafficking and 
function.  We demonstrate that ABHD17a is an 
acyl protein thioesterase that deacylates the 
STREX, but not S0-S1, domain of BK channels 
and in accordance with its specificity for the 
STREX domain controls channel activity rather 
than channel trafficking. 
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Results 
ABHD17a deacylates the BK channel STREX 
domain 
To define potential acyl thioesterases that control 
deacylation of the STREX domain of BK channels 
we first employed an imaging based screen that 
we have previously exploited to identify 
acyltransferases that S-acylate the STREX 
domain (17). In these assays we expressed the 
intracellular STREX-CRD domain of the BK 
channel (Figure 1B) as a -GFP fusion protein in 
HEK 293 cells.  As previously reported, 
expression of the isolated STREX-CRD domain 
results in robust expression of the fusion protein 
at the plasma membrane of HEK293 cells (Figure 
1C) due to endogenous S-acylation of the fusion 
protein (17). Membrane expression of the fusion 
protein is completely abolished by site directed 
mutagenesis of the tandem S-acylated cysteine 
residues (Cys645 and Cys646) to alanine in the 
STREX domain (STREX-CRD-C645:646A) 
resulting in predominantly cytosolic membrane 
expression. 
To examine potential acyl thioesterases that 
deacylate the STREX domain we co-expressed 
the STREX-CRD fusion protein with a battery of 
candidate acyl thioesterases (Figure 1D and 1E) 
including members of the ABHD (11, 21) and 
classical LYPLA families that showed robust 
expression in our HEK293 cell assay system 
(Figure 1D). Although activity based profiling and 
functional assays have suggested that the 
ABHD17 family, as well as ABHD12 and 
ABHD13, may have thioesterase activity against 
S-acylated proteins for the vast majority of ABHD 
family proteins their S-acyl thioesterase or other 
functions are not known (8, 11, 12). For example, 
ABHD 12 has also been shown to be a 
lysophopsholipid lipase whereas the function of 
ABHD13 is not known. Significantly out of 19 
putative acyl thioesterases tested only ABHD17a 
and ABHD17c had a significant effect on reducing 
membrane expression of the STREX-CRD fusion 
as predicted for an acyl thioesterase that 
deacylates the STREX domain. ABHD17a and 
17c have both been reported to control 
deacylation of a number of peripheral plasma 
membrane associated proteins (11, 21). 
However, expression of ABHD17a resulted in a 
larger and more consistent reduction in 
membrane expression of the STREX-CRD fusion 
protein compared to ABHD17c (Membrane 
expression expressed as a fraction (Mean ± SD) 
of that for STREX-CRD alone was: for ABHD17a 
0.38 ± 0.21 n = 28 and ABHD17c 0.57 ± 0.33, n = 
24, p<0.05 Kruskal Wallis with post-hoc Dunns 
test). In contrast, although ABHD17b was 
robustly expressed in HEK293 cells (Figure 1D), 
this closely related ABHD family member had no 
significant effect on STREX-CRD membrane 
association. Moreover, Lypla1 and Lyplal1 that 
we have shown previously (15) can deacylate the 
S0-S1 loop of BK channels, had no significant 
effect on STREX-CRD membrane localisation. 
To address whether ABHD17a and ABHD17c in 
fact deacylate the STREX domain of BK channels 
we used acyl-RAC assays to address acylation of 
the full length BK channel expressed in HEK293 
cells in the presence and absence of ABHD17a 
and ABHD17c. In addition, we addressed 
whether ABHD17a or ABHD17c is specific for the 
STREX domain by assaying whether 
overexpression of these acyl thioesterases will 
also deacylate the S0-S1 loop domain of the BK 
channel to ask if these ABHDs show specificity for 
distinct sites in the same polytopic 
transmembrane protein.  
We first assayed whether the S0-S1 domain is 
deacylated by ABHD17a and 17c by expressing 
the ZERO variant of the BK channel. The ZERO 
variant is identical to the STREX variant except 
that it lacks the alternatively spliced STREX insert 
but is S-acylated at the conserved S0-S1 loop. In 
control cells ZERO channels display robust and 
specific pull down in acyl-RAC assays only when 
the thioester bond between the endogenous lipid 
and the cysteine residues in the S0-S1 loop has 
been cleaved by hydroxylamine (+NH2OH) 
(Figure 2A). However, neither overexpression of 
ABHD17a or ABHD17c had any significant effect 
on ZERO channel pull down by acyl-RAC assay 
(Figure 2C) demonstrating the S0-S1 loop is not 
a target for these ABHDs.  
To address if the STREX domain is specifically 
deacylated by ABHD17a or ABHD17c we 
expressed STREX channels in which the S-
acylation sites in the S0-S1 loop have been 
mutated to alanine (STREX-C53:54:56A 
construct). STREX-C53:54:56A channels are 
robustly S-acylated and thus pulled down in acyl 
RAC assays from control HEK293 cells (Figure 
2B). Overexpression of ABHD17a and 17c both 
resulted in a significant (Figure 2B) reduction in 
S-acylated STREX-C53:54:56A channels 
captured in these assays (S-acylation expressed 
as a percentage of STREX-C53:54:56A alone 
was: for ABHD17a 26.8 ± 14.1%, n= 4, p< 0.01 
and for ABHD17c 57.5 ± 25.9%, n= 4, p< 0.05 
Kruskal Wallis with post hoc Dunn’s test). This 
supports the data form our imaging screen that 
ABHD17a and 17c deacylate the STREX domain 
to control its association with the plasma 
membrane. 
 
ABHD17a or 17c do not control surface 
expression of STREX BK channels 
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The acyl-RAC data suggest that ABHD17a and 
17c act specifically on the STREX domain of the 
BK channel, and have no effect on the S-acylation 
of the S0-S1 loop of the BK channel. To further 
test this specificity we first addressed whether 
ABHD17a or 17c controlled the surface 
expression of the BK channel. BK channel 
surface expression is attenuated in channels that 
are deacylated at the S0-S1 loop, as a result of 
increased retention in the trans Golgi network 
(15).  To assay BK channel surface expression 
we exploited an on-cell Western approach to 
assay surface expression of epitope tagged BK 
channels in cell population assays (16, 22). In 
these assays, the Flag- epitope at the 
extracellular N-terminus of the BK channel is 
used to assay channels that are resident at the 
cell surface  in intact cells, whereas the -HA 
epitope at the intracellular C-terminus of the 
channel allows assay of total BK channel 
expression in the same cells following cell 
permeabilization. The ratio of Flag to HA signal 
thus provides a reporter of BK channel surface 
expression as a function of total channel 
expression.  
We first assayed cell surface expression of the 
ZERO variant of the BK channel that lacks the 
STREX domain (Figure 3). In agreement with 
previous studies (15) co-expression with the 
cytosolic acyl thioesterase Lypla1 resulted in a 
significant reduction in ZERO channel surface 
expression as predicted as a result of deacylation 
of the S0-S1 loop (Figure 3B). In the presence of 
Lypla1 ZERO channel surface expression was 
0.28 ± 0.07 fold, n = 5 of ZERO channels alone. 
Surprisingly, overexpression of ABHD17a, but 
not ABHD17c, caused a small but significant 
increase in ZERO channel surface expression 
(Figure 3A & 3B).  However, this increase in 
surface expression was also observed with the 
catalytically inactive mutant of ABHD17a in which 
S170 and D255 in the catalytic triad were mutated 
to alanine (ABHD17a-mut) suggesting the 
enhancement of surface expression is not 
dependent on deacylation per se (Figure 3A & 
3B). In further support of this deacylation 
independent effect, overexpression of ABHD17a-
mut also had a small but significant enhancement 
of BK channel surface expression in ZERO 
channels that are S-acylation null (ZERO-
C53:54:56A) ruling out deacylation of the channel 
itself is involved in this stimulatory effect on 
surface expression (Figure 3A & 3D). ZERO, or 
ZERO-C53:54:56A, channel surface expression 
was not enhanced by the truncation mutant of 
ABHD17a (D19-ABHD17a) in which the N-
terminal 19 amino acids, that includes S-acylated 
cysteines important for membrane targeting (11), 
has been deleted (Figure 3A, 3B & 3D). Taken 
together, this unexpected enhancement of ZERO 
channel surface expression likely results from 
either a chaperone effect on the channel or a 
potential dominant negative effect of ABHD17a 
catalytic mutants on other components of the BK 
channel trafficking pathway.  
In contrast, ABHD17a, its catalytic or membrane 
targeting mutants, nor ABHD17c had no effect on 
STREX or STREX-C53:54:56A channel 
membrane expression (Figure 3A, 3C & 3E). 
Taken together, these data demonstrate that 
ABHD17a or 17c do not inhibit BK channel 
surface expression through deacylation of the S0-
S1 site in accordance with the lack of effect of 
these enzymes on S0-S1 loop S-acylation in acyl-
RAC assays. 
To test if the unexpected ABHD17a deacylation 
independent enhancement of ZERO channel 
surface expression was a result of reduced ZERO 
channel internalisation we exploited a population 
based assay of BK channel internalisation in 
HEK293 cells (16). ZERO BK channels at the cell 
surface were labelled at their extracellular N-
terminal Flag- tag epitope and allowed to 
internalise for 60 mins at 37oC before stripping of 
cell surface label allowing quantification of ZERO 
channel internalisation (Figure 4A). 
Approximately 30% of surface expressed ZERO 
BK channels internalised over this 60 minute 
assay in control HEK293 cells (Figure 4B & C). 
Overexpression of ABHD17a, or its catalytic 
(ABHD17a-mut) or membrane targeting (D19-
ABHD17a) mutant had no effect on ZERO 
channel internalisation (Figure 4C). This indicates 
that the enhancement of ZERO channel surface 
expression is likely due to deacylation 
independent effects of ABHD17a on forward 
trafficking and/or delivery of the channel to the 
plasma membrane rather than through 
decreased internalisation or stability at the 
plasma membrane. 
Deacylation of STREX domain by ABHD17a 
controls channel activity at the plasma membrane 
As ABHD17a had no effect on STREX channel 
surface expression we asked whether ABHD17a 
mediated deacylation of STREX has an effect on 
BK channel function and activity.  We have 
previously shown that channels that cannot be S-
acylated in the STREX domain are less sensitive 
to physiological voltages and intracellular free 
calcium levels compared to wild-type STREX 
channels (17, 19). To assay the effect of 
ABHD17a on STREX channel function we used a 
membrane potential assay in HEK293 cells in 
which heterologously expressed BK channels are 
stimulated upon calcium entry mediated through 
the calcium ionophore ionomycin (23, 24). In this 
assay simulation of mock transfected cells with 
ionomycin results in depolarisation of the 
  Site specific deacylation of BK channels by ABHD17a 
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membrane potential (Figure 5A) over the 180s 
time course of the assay as a result of calcium 
influx. Overexpression of ABHD17a had no 
significant effect on the time course or magnitude 
of the ionomycin-induce depolarisation of mock 
transfected HEK293 cells (Figure 5A). In cells 
overexpressing STREX channels ionomycin 
results in a rapid and transient hyperpolarisation 
of the membrane potential that typically remains 
significantly hyperpolarised compared to mock 
transfected cells over the time course of the 
assay (Figure 5A). Co-expression of ABHD17a 
with STREX channels resulted in a significantly 
attenuated peak hyperpolarisation in response to 
ionomycin (Figure 5A & 5B) that is ~ 60% smaller 
than the peak hyperpolarisation observed with 
STREX channels expressed alone. In the 
presence of STREX and ABHD17a the peak 
HEK293 hyperpolarisation was 0.41 ± 0.12 fold, n 
= 20, ** p< 0.01 Kruskal Wallis with post hoc 
Dunn’s test compared to HEK293 cells 
expressing STREX channels alone. Importantly, 
the inhibitory effect of ABHD17a on STREX 
channel activity was completely abolished using 
the catalytically inactive ABHD17a mutant 
(ABHD17a-mut) (Figure 5B). Moreover, the peak 
hyperpolarisation observed on co-expression of 
STREX channels with ABHD17a was similar to 
that observed in STREX channel S-acylation null 
mutants that cannot be S-acylated in the STREX 
domain (STREX-C645:646A). Furthermore, 
ABHD17a had no significant effect on the 
hyperpolarisation induced by ionomycin in 
STREX-C645:646A expressing HEK293 cells 
confirming the inhibitory effect is mediated via 
deacylation of the STREX domain.  Taken 
together, these data reveal that ABHD17a 
specifically deacylates the STREX domain of BK 
channels resulting in functional inhibition of 
STREX channel activity. 
 
Discussion 
Using a combination of an imaging-based screen, 
acyl-RAC and functional assays of BK channel 
trafficking and activity we reveal that ABHD17a is 
a major acyl protein thioesterase that site 
specifically deacylates the STREX domain of the 
BK channel to control channel activity.  Together 
with previous work (15),  these data reveal that in 
the same polytopic transmembrane protein 
different acyl protein thioesterases can control 
distinct sites with diverse functional impacts on 
channel behaviour. In the case of BK channels 
ABHD17a controls STREX domain and channel 
activity whereas Lypla1 (and a splice variant of 
Lyplal1) controls the S0-S1 domain and channel 
trafficking/functional coupling to  b-subunits (15, 
16) (Figure 6A).  Strikingly, these domains are 
also regulated by distinct acyl protein 
transferases supporting an increasing body of 
evidence that both acyltransferases and acyl 
protein thioesterases can display some target 
specificity as well as more promiscuous 
behaviour. 
To date, the majority of ABHD17 family targets for 
deacylation include a number of peripheral 
membrane proteins, that are targeted to plasma 
membranes via S-acylated domains such as Psd-
95, N-Ras and Mpp6 (11, 12, 14), rather than 
transmembrane proteins (Figure 6B). However, 
while ABHD17 members have been shown to 
display some selectivity between different 
proteins the mechanism(s) by which such 
selectivity may occur is not known. Moreover, 
how ABHD17a and Lypla1 respectively may 
discriminate between between the S0-S1 and 
STREX domains in BK channels remains unclear.  
Several potential mechanisms may be involved. 
Firstly, although some reports have suggested 
that Lypla1 can target the plasma membrane the 
majority of studies suggest it is a largely cytosolic 
protein whereas ABHD17a-c have a highly S-
acylated N-terminus and shown to target in 
plasma membranes in a variety of cell types (9, 
10). Thus, differential local accessibility of distinct 
BK channel loop domains from a cytosolic vs 
peripheral membrane location, or differential 
association of Lypla1 and ABHD17a with these 
distinct BK channel domains, may provide a 
mode of discrimination in cells.  
Secondly, ABHD targets defined to date (Figure 
6B) have candidate target cysteine residues in 
either the N- or C-terminal tails of peripheral 
membrane proteins there is no clear amino acid 
sequence consensus that might suggest 
discrimination of ABHD17 targets from other acyl 
thioesterases. Indeed, the classical acyl 
thioesterases Lypla1 and Lypla2 show both 
distinct and overlapping targets in accordance 
with their structural and sequence conservation 
with very similar surface polarity and substrate 
binding regions  (25). Lypla2 is likely more flexible 
than Lypla1 and as both have a single acyl 
binding pocket may explain preference of both 
enzymes for mono-acylated substrates but both 
have reduced activity. However, recent studies 
using short fluorogenic peptides in assay screens 
has provided some insight into vicinal amino 
acids surrounding a single cysteine amino acid 
that may change the efficiency of hydrolysis 
between Lypla1 and Lypla2. For example, 
positively charged residues in the downstream 
P1’ and P2’ positions enhance hydrolysis 
whereas  bulky aromatic residues in the upstream 
P1 and P2 positions limit hydrolysis (26).  
Previously identified ABHD family targets (Figure 
6B) have residues vicinal to S-acylated cysteines 
that would not, in general, be highly favourable for 
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hydrolysis by Lypla1 or Lypla2. However, the 
extent to which similar rules might apply to 
ABHD17 remains to be determined. Intriguingly in 
our assays ABHD17b had no effect on the 
STREX domain in our imaging screens whereas 
it is the major enzyme controlling PSD-95 
deacylation (12). Thus, how potential differences 
in deacylation efficiency between ABHD17 
isoforms remains to be explored.  
Furthermore, whether ABHD or Lypla family acyl 
protein thioesterases have differential effects 
when target cysteines are in clusters of di-
cysteine motifs remains to be examined. Again, 
available sequences of ABHD17 target proteins 
(Figure 6B) reveal that proteins with both clusters 
or di-cysteine motifs are targets such, as in the 
STREX domain, or in targets with lone cysteine 
residues. Moreover, the efficiency with which acyl 
thioesterases can catalyse hydrolysis of bound 
lipid species (depending on carbon backbone 
length or saturation) may also play an important 
role as in most cases the endogenous lipid, 
although often assumed to be palmitate, is not 
known for most S-acylated sites in proteins. 
The ability of different acyl protein thioesterases 
to target distinct S-acylated domains in the same 
polytopic transmembrane protein suggest that 
deacylation of these two domains may be both 
spatially and temporally controlled as has been 
proposed for peripheral membrane proteins such 
as N-Ras and Psd-95 as well as the microtubule 
binding protein MAP6 (12, 27).  The extent to 
which deacylation of these domains in BK 
channels is “constitutive’, dependent on the 
relative activity of competing zDHHC and acyl 
thioesterases, or might itself be dynamically 
controlled for example by environmental and/or 
signalling induced modulation of acyl protein 
thioesterase location and/or activity remains to be 
explored (28).   
In the course of these studies we observed a 
consistent and significant effect of catalytically 
inactive (ABHD17a-mut), but not inappropriately 
targeted D19-ABHD17a to enhance the surface 
expression of the ZERO variant of BK channels. 
This small stimulatory effect on surface levels 
was not observed in the BK channel STREX 
suggesting that overexpression of the 
catalytically null ABHD17a has distinct effects on 
the trafficking pathways controlling ZERO and 
STREX variant surface expression. Although S-
acylation of the S0-S1 domain has been reported 
to modify lateral mobility and surface expression 
of BK channels (29, 30) ABHD17a-mut had no 
effect on ZERO channel internalisation. 
Furthermore, this small enhanced surface 
expression upon ABHD17a-mut overexpression 
was also observed in S-acylation deficient ZERO 
BK channels (C53:54;56A) demonstrating this is 
independent of ZERO channel S-acylation but 
may result from changes in forward trafficking. 
Whether, overexpression of ABHD17a-mut 
results in affects on other components of the BK 
channel trafficking pathway, may act as a 
potential chaperone or may result from other 
activities or binding partners of ABHD17a 
warrants further investigation. For example, both 
Lypla1 and Lypla2, along with other ABHD family 
members display diverse functions, including 
hydrolysis of other lipids (8) but likely are 
functional monomers (25). Irrespective of 
mechanism, it does suggest that differences in 
forward trafficking for ZERO and STREX 
channels may exist.  
In summary, we have identified ABHD17a as a 
major acyl protein thioesterase that deacylates 
the STREX domain of BK channels to control 
channel activity independently of changes in cell 
surface expression. As ABHD17a and Lypla1 
target different domains of the BK channel this 
may: i) provide a suitable model to understand the 
rules controlling efficiency of acyl protein 
thioesterase to hydrolyse thioester lipid linkages 
in membrane proteins  and ii) allow us to unmask 
the mechanisms by which deacylation of distinct 
BK channels domains may control BK channel 




General biochemical reagents used throughout 
this study were obtained from Sigma-Aldrich and 
were of analytical-grade quality unless stated 
otherwise. 
HEK 293 cell culture and transfection 
HEK 293 cells were originally obtained from 
ATCC and cultured and transfected essentially as 
previously described (15–17). The cells were 
maintained in DMEM containing 10% fetal bovine 
serum (both Life Technologies), incubated at 37 
°C in 5% CO2 and used between passage 18 and 
30. HEK293 cells used in this study do not 
express endogenous BK channel subunits as 
determined by mRNA, protein, or functional 
assays (15–17). For transfection, cells were 
typically plated on 6-well plates for 24 h before 
transfection with corresponding plasmid cDNA 
using PolyJet (tebu-bio). In all co-transfection 
assays channel cDNAs were transfected at a 1:1 
ratio with acyl thioesterases or empty pcDNA3.1 
plasmid in controls.  
BK channel and acyl thioesterase constructs 
The generation of BK channel ZERO and STREX 
variant subunits with an extracellular N-terminal 
FLAG-  and intracellular C-terminal -HA epitope 
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tags in pcDNA3, together with S-acylation 
deficient site directed mutants and the STREX-
CRD domain as a -YFP fusion have been 
described previously (15–17). Original ABHD 
family clones as Flag-tagged constructs in the 
pCAGGS vector were a generous gift of 
Professor Masaki Fukata (21) and used in the 
initial imaging screens in Figure1. Lypla1, Lypla2 
and Lyplal1 clones were as previously described 
(15).  A catalytically inactive version of ABHD17a 
was made by mutating amino acids S170 and 
D255 in the catalytic triad to alanine by 
synthesising the entire coding sequence (Twist 
Bioscience) containing the mutated amino acid 
codons and incorporating the FLAG tag and 
restriction sites EcoRI and NotI flanking the 
coding sequence and subcloned into pcDNA3.1. 
The targeting deficient ABHD17a mutant (11, 21) 
that lacks the first 19 amino acids at the N-
terminus including S-acylated cysteine residues 
required for membrane targeting (D19-ABHD17a) 
was generated by PCR using a forward primer 
containing an EcoRI restriction site and a start 
methionine, 5’-
AAAGAATTCACCATGGGCCGCATCGCGCGG
CCAAG-3’, and a reverse primer to amplify a KpnI 
site in the original sequence 5’-
CCACTGCAGCACACTCATAACG-3’ were used 
to PCR amplify the clone, subcloning back into an 
empty pCAGGS vector. For assays in which 
ABHD17a enzymes were co-expressed with 
Flag- and -HA epitope tagged BK channels the 
Flag tags of the corresponding full length 
ABHD17a clones was engineered to a myc- 
epitope tag by PCR. Briefly, full length constructs 
were amplified by PCR using the primers, 
Forward (including a BamHI site) 5’-
GCCGGATCCGGCCACCATGAACGGCCTGTC
GGTGAGCGAGCTC-3’ and Reverse (including a 
XbaI site) 5’-
TGGTCTAGATTACAGATCCTCTTCTGAGATG
AGTTTTTGTTCGGTGCGTTGG-3’ and the 
amplicons subcloned into pcDNA3.1. To 
generate myc tagged  D19-ABHD17a, the forward 
primer used to generate D19-ABHD17a was used 
with the myc reverse primer and cloned into 
pcDNA3.1 by restriction digest using EcoRI and 
XbaI.  All clones were validated by DNA 
sequencing. 
STREX-CRD imaging assay 
Cells were processed, imaged and quantified 
essentially as described (17). In brief, HEK293 
cells were plated on glass coverslips, transfected 
as above and 48h later fixed with 4% ice-cold 
paraformaldehyde for 15 min at room 
temperature. After quenching with 50 mM NH4Cl, 
cells were either first probed for the epitope tag of 
the corresponding acyl thioesterase before 
mounting on microscope slides using Mowiol or 
Fluorsave. Cells were initially screened using an 
epifluorescence microscope with a 100x oil 
objective lens. Confocal images were acquired on 
either a Nikon A1 or Zeiss LSM510 laser 
scanning microscope, using a 63x oil Plan 
Apochromat (N.A. = 1.4) objective lens. The 
majority (> 90%) of experiments were performed 
blind by an observer independent from the 
experimentalist undertaking the cell transfections. 
Membrane expression was typically observed in 
>95% of HEK293 cells transfected with the 
STREX-CRD fusion protein. To determine 
membrane expression upon co-expression with 
putative acyl thioesterases line scans of 
fluorescent intensity through 4 independent areas 
of the plasma membrane, cytosol and nucleus of 
cells were analyzed using Fiji software (NIH).  To 
determine plasma membrane localisation a signal 
intensity at the cell periphery that was 2 SD 
greater than that in the cytosol in any of the 4 
planes was defined as a cell with membrane 
expression. For each coverslip 3–5 random fields 
of view were analyzed to determine the number 
of transfected cells with plasma membrane 
localization of the STREX-CRD fluorescent fusion 
protein. The average percentage of transfected 
cells from each coverslip (minimum 50 cells per 
coverslip) that displayed membrane expression 
was then normalized to the corresponding wild-
type STREX-CRD control in each independent 
experiment.   
On cell Western cell surface expression assays 
Assays were carried out as described previously 
(16, 22). Transfected HEK293 cells were plated 
into a 96 well poly-d-lysine coated, black walled, 
clear bottom plate (Greiner) and assayed 48 h 
post-transfection. Cells were stained on ice in 
growth medium (GM: DMEM + 10% foetal bovine 
serum) for the FLAG epitope applying mouse 
anti-FLAG-M2 (Sigma, 1:100 in GM), then 
washed in GM and stained for 1 h with anti-mouse 
IRDye800CW goat IgG (Licor, 1:100 in GM). Cells 
were then fixed, permeabilized and blocked in 
Odyssey Blocking Buffer (OBB) before staining at 
room temperature for 1 hr with anti-HA antibody 
(Immune Systems, 1:1000 in OBB) followed by 
anti-rabbit secondary IRDye690RD (Licor, 1:500 
in OBB). Separate wells were stained with TO-
PROTM-3-iodide (1:500) to account for cell 
number. Cell staining was imaged on an Odyssey 
IR imager and were analyzed using Image Studio 
Lite Ver5.2 (freeware from Licor). Staining 
intensity was normalized to cell number and 
background-subtracted before calculating the 
ratio of surface FLAG:HA total protein staining.  
BK channel internalization assay 
Assays were carried out as described previously 
(16). Transfected HEK293 cells were plated into 
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a 96 well poly-d-lysine coated, black walled, clear 
bottom plate (Greiner) and assayed 48 h post-
transfection. All cells were stained on ice for the 
FLAG epitope, anti-FLAG-M2 (1:100 in DMEM + 
10% foetal bovine serum (GM)), washed in GM 
then stained with anti-mouse IRDye800CW 
(1:1000 in GM). Ice-cold stripping buffer 
(0.1 M glycine, 0.1 M NaCl, pH 2.5, in PBS) was 
immediately applied to a subset of wells and then 
washed in growth medium to determine 
background staining. To allow endocytosis and 
internalization of labelled channels to occur, cells 
were incubated at 37 °C in a humid chamber for 
1 h. The cells were then cooled on ice and a 
subset of cells were stripped to measure 
internalized staining with a further subset 
remaining unstripped to measure total FLAG 
staining. All cells were then stained for 30 mins 
on ice with NucRedTM Live 647 
ReadyProbesTM reagent (ThermoFisher) to 
account for cell number. Cells were imaged on an 
Odyssey IR Imager and analyzed using Image 
Studio Lite version 5.2. For each well, staining 
intensity of FLAG was normalized to the NucRed 
signal. Background signal detected in time 0 
stripped cells (i.e. no internalization) was 
averaged and subtracted from the other wells. 
Remaining signal detected after stripping 
treatment in the 60 min, 37 °C incubation wells 
was then normalized to the total surface staining 
in the unstripped wells, and expressed as a 
percentage of total BK channel surface 
expression without stripping. 
Acyl-RAC of BK channel S-acylation 
Acyl-RAC experiments were based on the 
protocol as previously described (15, 31). 
Transfected cells were lysed 48 h post 
transfection in blocking buffer (100 mM HEPES, 
1 mM EDTA, and 2.5% SDS, pH 7.5), disrupting 
cells using a 21-gauge needle and syringe for 20 
strokes. Lysates were treated with 0.1% 
methanethiosulfonate (MMTS) and incubated for 
4 h at 40 °C with shaking. Proteins were 
precipitated in acetone and stored at -20 °C 
overnight before washing five times in 70% 
acetone to remove the MMTS and allow protein 
resuspension by dissolving precipitate in 300 μl of 
binding buffer (100 mM HEPES, 1.0 mM EDTA, 
1% SDS, pH 7.5). After removal of 20 μl for input 
analysis, the remaining blocked proteins were 
divided into two tubes and treated with either 
0.3 M hydroxylamine (NH2OH; Scientific 
Laboratory Supplies) or 0.3 M NaCl, pH 7.5. 
Thiopropyl-Sepharose beads were rehydrated in 
a 1:1 slurry in binding buffer, and 50 μl of beads 
was added to each tube, incubating for 2.5 h at 
room temperature. After bead capture, the 
samples were centrifuged at 13,000 × g for 1 min 
and washed five times in binding buffer. The 
proteins were then eluted in 50 μl of 2× SDS-LB 
heated to 60 °C for 10 min. Proteins were 
analysed by 10% SDS-PAGE, loading 10 ul of 
input sample and 20 ul of eluted proteins and 
probed by Western blot for anti-FLAG. For 
quantitation, signals from the corresponding 
+NH2OH lane were first normalised to the input 
signal for that assay. Data for the effect of the 
respective thioesterase was then expressed as a 
percentage of S-acylation of the corresponding 
ZERO or STREX-C53:54:56A channel expressed 
alone. 
Membrane Potential Assay 
Membrane potential assays were carried out as 
detailed previously for analysis of BK channel 
activity in HEK293 cells (23, 30). Transfected 
HEK293 cells were plated into a 96 well poly-d-
lysine coated, black walled, clear bottom plate 
(Greiner) and assayed 48 h post-transfection. 
Cells were incubated with FLIPR® Membrane 
Potential Blue Dye (Molecular Devices, 
Sunnyvale, CA) containing 2 mM CaCl2, for 30 
min at room temperature. Assays were performed 
using the Flexstation R II system (Molecular 
Devices) at 22 oC by addition of the calcium 
ionophore ionomycin (0.83 µM final) after 16s. 
Fluorescent measurements as relative 
fluorescence units (RFU) were determined over a 
period of 180s. In this assay an increase in BK 
channel activity results in a hyperpolarisation 
which is detected as a decrease in fluorescence 
and is fully blocked by the specific 1 µM of the BK 
channel inhibitor paxilline (23). The assay is 
optimised to drive BK channel activation by 
elevation of intracellular free calcium that peaks 
approximately 40s following ionomycin addition 
before declining (23). As S-acylated STREX 
channels show increased apparent calcium 
sensitivity, without a significant change in voltage 
sensitivity compared to de-acylated STREX-
C645:646A channels (17-19, 23), the peak 
calcium induced hyperpolarising response at ~ 
50s represents the most sensitive component of 
the assay to discriminate functional S-acylation of 
STREX channels. To compare between 
conditions the RFU for each well was first 
normalised to its basal (pre ionomycin stimulus) 
RFU over the first 16s or recording as shown in 
Figure 5A. To allow quantification between 
experiments, as in Figure 5B, the peak 
hyperpolarising response in STREX expressing 
cells in each experiment was determined and 
subtracted from the corresponding HEK293 
control and the peak response then expressed as 
a fraction of the peak hyperpolarisation in cells 
expressing STREX channels alone.  
Statistics 
  Site specific deacylation of BK channels by ABHD17a 
 9 
The data are expressed as Mean ± SD, n = 
number of independent experiments. Statistical 
analysis was performed, as appropriate, by one 
ANOVA with Sidak post hoc multiple comparison 
tests for multiple comparisons of parametric data 
and using Kruskal Wallis test with Dunn’s post-
hoc test for non-parametric data (GraphPad 
Prism 8). Significant differences between groups 
were defined at * p < 0.05 and ** p < 0.01. 
Data availability 
All data are presented in the article, or are 
available from the corresponding author (Michael 
J Shipston, University of Edinburgh, 
mike.shipston@ed.ac.uk) on request. 
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ABHD17a controls plasma membrane association of BK channel STREX domain 
A) Schematic of pore-forming subunit of the STREX BK channel splice variant indicating the two S-
acylated domains of the channel: the S0-S1 loop present in all channel variants, and the alternatively 
spliced STREX insert in the intracellular C-terminus of the channel located between the two regulator 
of potassium conductance (RCK) domains. B) The isolated S-acylated STREX-CRD fusion protein is 
associated with the plasma membrane when expressed in HEK293 cells and remains cytosolic when 
deacylated. C) Representative confocal sections of HEK293 cells expressing the STREX-CRD (as a -
GFP fusion protein) and upon co-expression with ABHD17a. Scale bars are 2 µm. D) Immunostaining 
of populations of HEK293 cells in 96 wells for overexpressed Flag-tagged putative acyl thioesterases 
from the ABHD and Lypla families. E) Quantification of membrane expression of STREX-CRD, as a -
GFP fusion protein, in HEK293 upon co-expression with ABHD and Lypla acyl thioesterase family 
members. Data are expressed as the fraction of cells expressing STREX-CRD at the plasma membrane 
in comparison to cells expressing STREX-CRD alone. Data are Means ± SD, n = 23-54 independent 
experiments per group. ** p < 0.01, * p< 0.05 compared to STREX-CRD alone, non-parametric Kruskal 
Wallis with post hoc Dunn’s test. 
 
Figure 2 
ABHD17a deacylates the BK channel STREX, but not S0-S1 loop, domain 
Representative Western blots from an acyl-RAC assay of A) ZERO BK channel variant that lacks the 
STREX domain or B) the STREX-C53:54:56A mutant that cannot be S-acylated in the S0-S1 loop, 
expressed in HEK293 cells alone or with ABHD17a or ABHD17c. Cell lysate input to the acyl-RAC 
assay is shown together with pull downs following cleavage of thioester bond with hydroxylamine 
(+NH2OH) or in salt control (-NH2OH). Quantification of S-acylation of C) ZERO or D) STREX-
C53:54:56A in the presence of ABHD17a or ABHD17c. Data are expressed as percentage of S-
acylation of corresponding ZERO or STREX-C53:54:56A channel alone (Control) as Means ± SD, n = 
4 independent experiments per group. ** p < 0.01, * p< 0.05 compared to STREX-C53:54:56A alone, 
non-parametric Kruskal Wallis with post hoc Dunn’s test. 
 
Figure 3 
ABHD17a dependent deacylation does not control BK channel surface expression 
A) Representative on-cell western assay of cell surface expression of epitope tagged BK ZERO, ZERO-
C53:54:56A and STREX channels alone or co-expressed with wild-type β1 or co-expressed with wild-
type ABHD17a, the catalytically inactive ABHD17a mutant (ABHD17a-mut) or the N-terminally 
truncated, targeting deficient ABHD17a (D19-ABHD17a). Surface BK channel was quantified using an 
extracellular FLAG-tag (green) while total BK expression was measured using an intracellular -HA tag 
(red) following cell permeabilization. Four replicates from an individual experiment are shown. (B to E) 
Quantification of corresponding BK channel surface expression in the presence of acyl thioesterases 
and their related mutants as in A) and expressed as a fraction of the corresponding BK channel subunit 
expressed alone.  Data are Means ± SD, n = 5-17 independent experiments per group. ** p < 0.01, * 
p< 0.05 compared to corresponding BK channel group alone, non-parametric Kruskal Wallis with post 
hoc Dunn’s test. 
 
Figure 4 
ABHD17a does not control BK channel internalisation 
A) Schematic of internalisation assay and B) representative images from an internalisation assay of 
epitope tagged ZERO BK channels alone or co-expressed with ABHD17a and it mutants in HEK293 
cells. Internalised BK α-subunit was quantified, after 60 min at 37°C, using the extracellular FLAG- tag 
(green) following acid-strip of surface staining in non-permeabilised cells and normalised to surface 
expression at time zero. Four replicates from an individual experiment are shown. (C) Quantification of 
BK channel α-subunit internalisation as a percentage of initial total surface expression. Data are Means 
± SD (n = 4 independent experiments per group).  
 
Figure 5  
ABHD17a mediated deacylation of the STREX domain inhibits STREX channel function 
A) Representative experimental time courses of ionomycin (1µM started at 16s, horizontal grey bar) 
induced changes in membrane potential of HEK293 cells transfected with STREX channel variants and 
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ABHD17a using a 96-well format cell population Flexstation membrane potential assy.  Positive 
changes in relative fluorescence units (RFU) denote membrane depolarisation, whereas negative 
changes in RFU reflect membrane hyperpolarisation. Assays were performed in physiological ion 
gradients with 2mM extracellular calcium. Data are Means ± SD from a single typical independent 
experiment with 8 experimental replicates. B) Quantification of peak hyperpolarisation response to 
ionomycin in membrane potential assays expressed as a fraction of the peak hyperpolarisation in cells 
expressing STREX channels alone. Data are Means ± SD, n = 5-20 per group. ** p< 0.01 compared to 
STREX, non-parametric Kruskal Wallis with post hoc Dunn’s test. 
 
Figure 6  
Distinct acyl protein thioesterases control deacylation at distinct sites in BK channels  
A) Schematic of the STREX variant of the BK channel pore forming subunit (Kcnma1) and sites of S-
acylation. The STREX domain is deacylated by Abhd17a and the S0-S1 domain by Lypla1. B) Amino 
acid sequence of other targets for ABHD17 acyl thioesterases showing the 10 most vicinal residues 
surrounding S-acylated cysteines.  Mouse sequences and numbering is used throughout and include 
proteins with S-acylation at the i) N-terminus including Psd-95 (11, 12), Gap-43 (12) and Map6 (27); ii) 
internal/intracellular loop cysteines such as Mpp6 (14) and the STREX variant of Kcnma1 shown here 
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RCK 1
RCK 2
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STREX
STREX
STREX 
BK channel variant
Lypla1 Abhd17a
N-terminal
C-terminal
Internal/intracellular loop
MDC3LC5IVTTKKYRYQ...Psd-95
Map6 MAWPC5ITRAC10C11IARFWNQLDK...
Gap-43 MLC3C4MRRTKQVEKN...
N-Ras ...LNSSDDGTQGC181MGSPCVVM
H-Ras ...LNPPDESGPGC181MSC184KCVLS
Mpp6 ...RRDWDNSGPFC311GTISNKKKKK...
Kcnma1 (STREX) ...MSIYKRMRRAC645C646FDCGRSERDC...
A
B
